EM1602G "Management of Advanced Hepatocellular Carcinoma" (IM GR020516)
To review the systemic treatment of unresectable Hepatocellular Carcinoma.
Target Audience
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Understand the challenges and goals of systemic therapy for HCC.
- Understand the history of clinical trials in advanced HCC.
- Define the standard of care for advanced, unresectable HCC.
- Overview of failed therapies tested in Phase 3 trials.
Hao Zhu, M.D.
Assistant Professor
Children’s Medical Center Research Institute and Pediatrics
Division of Hematology and Oncology
Available Credit
- 1.00 AMA
Price
Cost:
$0.00
Please login or create an account to take this course.
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome